Eleva is a privately funded biotechnology company based in Freiburg im Breisgau, Germany. Since its foundation in 1999, the company has developed a moss-based technology platform that enables the production of complex proteins for the treatment of various diseases, some of which are rare and underserved. In addition, Eleva has successfully completed a clinical trial with a moss-based biopharmaceutical and is planning the second clinical trial.
Our team currently consists of 39 outstanding colleagues who contribute to our friendly and straightforward corporate culture. With their work, our employees make a difference in the development of new therapies for patients around the world.